anti-ARHGDIB antibody product blog
Tags: Antibody; Polyclonal Antibody; ARHGDIB; anti-ARHGDIB antibody;
The ARHGDIB arhgdib (Catalog #MBS422430) is an Antibody produced from Goat and is intended for research purposes only. The product is available for immediate purchase. The Goat anti-ARHGDIB Antibody reacts with Tested: Human; Expected from sequence similarity: Human, Dog, Pig, Cow and may cross-react with other species as described in the data sheet. MyBioSource\'s ARHGDIB can be used in a range of immunoassay formats including, but not limited to, Peptide ELISA (EIA), Western Blot (WB).Peptide ELISA: Antibody detection limit dilution 1: 4000.
Western Blot: Approx 26kDa band observed in lysates of cell line Jurkat (calculated MW of 23. 0kDa according to NP_001166.3). Recommended concentration: 1-3ug/ml. Researchers should empirically determine the suitability of the ARHGDIB arhgdib for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The ARHGDIB arhgdib product has the following accession number(s) (GI #56676393) (NCBI Accession #NP_001166.3). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful. The amino acid sequence is listed below:
TEKAPEPHVE.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the Goat anti-ARHGDIB Antibody with the following immunoassay(s):
Western Blot (WB) ((0.1ug/ml) staining of Jurkat lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.)
Immunogen: Peptide with sequence TEKAPEPHVE-C, from the N Terminus of the protein sequence according to NP_001166.3.
Epitope: N Terminus. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing ARHGDIB are readily searchable from our website. Different antibodies against the same target such as ARHGDIB may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. ARHGDIB also interacts with the following gene(s): CDC42, RAC1, RAC2, RAC3, RHOA, RHOB, RHOC, RHOG. Bladder, Blood, Bone, Bone Marrow, Liver, Lung, Lymph, Lymph Node, Muscle, Stomach tissues are correlated with this protein. The following patways have been known to be associated with this gene. Adenocarcinoma, Breast Neoplasms, Carcinoma, Inflammation, Liver Neoplasms, Lung Diseases, Lung Neoplasms, Neoplasms, Experimental, Ovarian Neoplasms, Urinary Bladder Neoplasms are some of the diseases may be linked to Goat anti-ARHGDIB Antibody.